Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access
Microbot Medical Inc. (MBOT)
Last microbot medical inc. earnings: 11/14 03:34 pm
Check Earnings Report
US:NASDAQ Investor Relations:
microbotmedical.com/investors
Company Research
Source: GlobeNewswire
Livestream Interview Can be Viewed Today at 10:50am ET at Benzinga All Access Live BRAINTREE, Mass., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Microbot Medical® Inc. (Nasdaq: MBOT), developer of the innovative single use LIBERTY® Endovascular Robotic System, announces that its Chief Executive Officer, Harel Gadot, will be interviewed on Benzinga All Access at 10:50am ET on December 10, 2024. The live interview can be viewed at: Benzinga All Access Live. Mr. Gadot will discuss Microbot Medical’s LIBERTY system, the continued growth and adoption of surgical robotics, and how the Company plans to redefine the peripheral endovascular space with LIBERTY®. Earlier today, the Company announced that it has submitted the FDA 510(k) for commercialization of the LIBERTY® Endovascular Robotic System. As the world’s first single-use, fully disposable endovascular robotic system, LIBERTY® eliminates the need for large and expensive capital equipment and streamlines customers’ access to robotics. With
Show less
Read more
Impact Snapshot
Event Time:
MBOT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MBOT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MBOT alerts
High impacting Microbot Medical Inc. news events
Weekly update
A roundup of the hottest topics
MBOT
News
- Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access [Yahoo! Finance]Yahoo! Finance
- Microbot Medical® Announces FDA Submission for the Commercialization of the LIBERTY® Endovascular Robotic System [Yahoo! Finance]Yahoo! Finance
- Microbot Medical® Announces FDA Submission for the Commercialization of the LIBERTY® Endovascular Robotic SystemGlobeNewswire
- Microbot Medical completes human clinical trial in its ACCESS-PVI [Seeking Alpha]Seeking Alpha
- Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025 [Yahoo! Finance]Yahoo! Finance
MBOT
Sec Filings
- 12/19/24 - Form 8-K
- 12/10/24 - Form 424B3
- 12/10/24 - Form 424B3
- MBOT's page on the SEC website